REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
XTX Topco Ltd | 10,215 | $329,025 | 0.07% |
Capital World Investors | 10,076,101 | $324,551,213 | 0.07% |
TWINBEECH CAPITAL LP | 98,684 | $3,178,612 | 0.06% |
OCCUDO QUANTITATIVE STRATEGIES LP | 21,918 | $705,979 | 0.06% |
SEVEN EIGHT CAPITAL, LP | 8,909 | $286,959 | 0.06% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 254,000 | $8,181,340 | 0.06% |
Caption Management, LLC | 93,500 | $3,011,635 | 0.06% |
Engineers Gate Manager LP | 40,684 | $1,310,432 | 0.06% |
NOTTINGHAM ADVISORS, INC. | 12,179 | $392,286 | 0.05% |
AIGEN INVESTMENT MANAGEMENT, LP | 11,838 | $381,302 | 0.05% |
Accredited Investors Inc. | 20,491 | $660,015 | 0.05% |
JENNISON ASSOCIATES LLC | 1,633,305 | $52,608,757 | 0.05% |
CENTAURUS FINANCIAL, INC. | 15,881 | $512 | 0.04% |
Flaharty Asset Management, LLC | 6,952 | $223,924 | 0.04% |
Centiva Capital, LP | 50,000 | $1,610,500 | 0.04% |
BLAIR WILLIAM & CO/IL | 306,877 | $9,884,508 | 0.04% |
FRANKLIN RESOURCES INC | 2,274,491 | $73,261,357 | 0.04% |
Y-Intercept (Hong Kong) Ltd | 10,009 | $322,390 | 0.04% |
Inspire Investing, LLC | 8,464 | $272,625 | 0.04% |
PROFUND ADVISORS LLC | 17,021 | $548,246 | 0.03% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.